AmpliTech Receives Over $400,000 in New Orders BOHEMIA,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AmpliTech Receives Over $400,000 in New Orders

BOHEMIA, N.Y., March 3, 2015 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (OTCQB:AMPG) announced today that it has received new orders valued at over $400,000 from international government and domestic private customers within the last 2 months. These new orders are for products for which AmpliTech has primarily been a sole source due to its unique and unparalleled performance attributes that have made AmpliTech the number one choice for our customers worldwide. These initial new orders are expected to position AmpliTech on long term supply chain roadmaps to provide its innovative and high performance products and solutions to mission critical programs.   

CEO Fawad Maqbool stated, "AmpliTech's core product line is a perfect lead-in for the company in pursuit of its strategic objectives for large scale commercialization of its innovative technologies to drive the new product pipeline currently in the development for its newly formed Wireless Solutions Group. Clearly, what we are seeing is that the demand for our products is on the rise and is expected to substantially increase as we move forward with the transition into mass markets in line with our company strategy and vision as stated in previous press releases. We anticipate the increase in our bookings and backlog to continue throughout the remainder of the year as we move forward with our initiatives to shape the future of AmpliTech product offerings."

About AmpliTech Group, Inc.

AmpliTech Group, Inc. is an innovative provider of advanced radio frequency technology solutions serving applications from 50 kHz to 100 GHz across a diverse mix of markets. AmpliTech designs, develops, and manufactures custom and standard state-of-the-art RF and microwave and millimeter-wave components and integrated modules for the Domestic and International, SATCOM , Space , wireless infrastructure, test & measurement, and Military markets. In addition to our product offerings we leverage our design and product development expertise and core competencies to provide consulting and manufacturing services to our customers helping them reduce design cycle time and cost, achieve faster time to market, and lower manufacturing costs. Our steady growth over the past 13+ years has been the result of our commitment to not only meet, but to exceed the rigorous performance, quality, and reliability requirements of our diverse mix of customers. Click here to view AmpliTech video. Website: http://www.AmpliTechinc.com

Forward-looking Statements

This release contains statements that constitute forward-looking statements. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

Fawad Maqbool, CEO AmpliTech Group, Inc. (631) 521-7831

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 11

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Formation Unveils First Solana Tokenized Securities Venue

Updated Category News Views 22

Well, here we go. Formation Securities is setting sail on the high seas of blockchain, aiming to operate a tokenized securities venue (TSV) on Solana. This isn't your garden-variety launch—it's a bold leap into a newer, faster-paced world of trading. Sure, you’ve heard about blockchains before, but this operation marries the traditional rigmarole of the stock market...

Continue Reading
Continuous Insulation Market Grows, Hits $67.74B by 2031

Updated Category News Views 19

Market Trends and Key Drivers Imagine riding a slow but steady bull market in insulation—sounds mundane, but the numbers don't lie. MarketsandMarkets™ had the scoop, predicting the Continuous Insulation Market will balloon from USD 56.98 billion in 2026 to USD 67.74 billion by 2031, putting down roots with a 3.5% CAGR. Now, you and I both know that when real estate...

Continue Reading
Tigo Energy Faces Class Action: Investor Deadline Looms

Updated Category News Views 5

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 130

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 99

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Captain D's Expands Globally with New Franchise Agreement

Updated Category News Views 653

Captain D's Takes a Giant Leap into Global Expansion In a significant move for its global growth strategy, Captain D's, the leading fast-casual seafood restaurant in the nation, has signed a major franchise agreement aimed at establishing its brand in the UK. This new venture marks a noteworthy milestone as the company prepares to serve its renowned seafood offerings to a...

Continue Reading
Understanding Your Rights as an Alto Neuroscience Shareholder

Updated Category News Views 129

Understanding Your Rights as an Alto Neuroscience Shareholder Alto Neuroscience, Inc. (NASDAQ: ANRO) has recently been in the spotlight as shareholder rights issues arise. For those investors who acquired shares, it is important to understand the implications of these developments and the actions that may be available to you. Why Should Shareholders Take Action? As a...

Continue Reading
Taiwan Fund, Inc. Shares Key Stockholder Meeting Outcomes

Updated Category News Views 170

The Taiwan Fund, Inc. Announces Stockholders Meeting Results The Taiwan Fund, Inc. (TWN), a prominent closed-end investment entity, recently revealed the outcomes of its Annual Stockholders Meeting. This important event, focusing on the future direction of the Fund, showcased a solid commitment from investors as they participated in key voting processes. Board of...

Continue Reading
Canadian Solar Inc. Delivers Solid Q2 2025 Financial Results

Updated Category News Views 295

Strong Performance by Canadian Solar Canadian Solar Inc. (NASDAQ: CSIQ) has recently reported its impressive financial results for the second quarter. The highlights include an increase in solar module shipments, reflecting the company's ongoing advancement in the renewable energy sector. Second Quarter Highlights The second quarter showcased a 14% quarter-over-quarter...

Continue Reading
Otto Aviation Partners with Galorath for Enhanced Cost Estimation

Updated Category News Views 219

Otto Aviation Partners with Galorath for Enhanced Estimation In a groundbreaking move, Otto Aviation has made a strategic decision to standardize its operations on Galorath's AI-powered estimation platform. This collaboration is set to significantly enhance Otto's pricing strategies as it ventures into sustainable aerospace projects, aiming to revolutionize the future of...

Continue Reading